Communiqué de presse

April 14, 2023 11:42 AM

Updated statement regarding LockBit claims

Mike Beck, Chief Information Security Officer, Darktrace

We have completed a thorough security investigation following yesterday’s tweets by LockBit claiming they had compromised Darktrace’s internal systems. We can confirm that there has been no compromise of our systems or any of our affiliate systems. Our service to our customers remains uninterrupted and is operating as normal and no further action is required.

Communiqué de presse

April 13, 2023 9:30 AM

Statement regarding LockBit claims

Earlier this morning we became aware of tweets from LockBit, the cyber-criminal gang, claiming that they had compromised Darktrace’s internal security systems and had accessed our data. Our security teams have run a full review of our internal systems and can see no evidence of compromise. None of the LockBit social media posts link to any compromised Darktrace data. We will continue to monitor the situation extremely closely, but based on our current investigations we are confident that our systems remain secure and all customer data is fully protected.


Communiqué de presse

Critical Intellectual Property Safeguarded with Darktrace AI

Artificial Intelligence Defends Sensitive Client IP at Leading Pharma Manufacturer
San Francisco
October 17, 2017

Media coverage

News publication logo

Critical Intellectual Property Safeguarded with Darktrace AI

Read the story
October 17, 2017

Darktrace, the world leader in AI technology for cyber defense, has today announced that CordenPharma, a leading pharma manufacturer, has selected its AI technology to defend its clients’ critical intellectual property, including drug registration applications, molecular formulae, patient records, production processes, and manufacturing records.

Intellectual property is the bedrock on which pharmaceuticals’ development and manufacturing is built,” commented Brandon Frontz, IT Systems and Network Administrator, CordenPharma. “With drugs and medication manufacturing, the clients’ trust in our services is critical. Darktrace’s AI empowers us to defend pharmaceutical companies’ highly sensitive data against sophisticated attacks, including ‘unknown unknowns’, and to maintain that trust.”

Powered by machine learning and AI algorithms, the Enterprise Immune System is capable of detecting subtle and sophisticated threats that are routinely missed by traditional security tools. It works by building an understanding of what constitutes the normal ‘pattern of life’ for CordenPharma’s network and leverages that understanding to detect emerging attacks. It can then generate a precise autonomous response, neutralizing threats within seconds.

It is critical that all pharmaceutical companies recognize that threats are only increasing in speed and sophistication,” said Rob Sass, Managing Director, North America, Darktrace. “By choosing Darktrace, CordenPharma is armed with AI that is capable of detecting cyber-threats of all types, including novel and stealthy attacks.”

About Darktrace

About Darktrace

Darktrace is the world’s leading machine learning company for cyber security. Created by mathematicians from the University of Cambridge, the Enterprise Immune System uses AI algorithms to automatically detect and take action against cyber-threats within all types of networks, including physical, cloud and virtualized networks, as well as IoT and industrial control systems. A self-configuring platform, Darktrace requires no prior set-up, identifying advanced threats in real time, including zero-days, insiders and stealthy, silent attackers. Headquartered in San Francisco and Cambridge, UK, Darktrace has 30 offices worldwide.

share this article